(Re)in Summary
• AIA Singapore and NHG Health’s partnership aims to develop effective models of care and deliver value-based care for policyholders at sustainable costs.
• NHG Health stated that the collaboration is designed to address community health challenges by aligning financing with healthier behaviours and prioritising prevention and early intervention.
AIA Singapore announced its collaboration with NHG Health on population healthcare initiatives, aimed at improving long-term sustainability and affordability of care for residents
During the signing of the memorandum of understanding on Wednesday, 24 September, at Khoo Teck Puat Hospital, AIA stated that the partnership will focus on exploring effective models of care, delivering value-based care for policyholders at sustainable costs, as well as improving population health.
Wong Sze Keed, CEO of AIA Singapore, said the partnership combines AIA’s health insurance expertise with NHG’s clinical and public health capabilities to develop solutions that improve care quality, reduce costs, and address community health needs.
Speaking about the announcement, NHG Health Group CEO Professor Joe Sim reiterated the company’s commitment to providing population health and preventive care for Singaporeans in the central and northern regions.
“This collaboration will enable us to align financing with healthier behaviours, drive prevention, and early intervention so that both individuals and our health ecosystem benefit from cost efficiencies and better quality of life,” Sim added, while recognising AIA’s expertise in risk management and wellness initiatives.
This move mirrors AIA’s broader efforts within Asia’s healthcare sector. In 2025, the business launched a digital health collaboration with Korea’s Kakao Healthcare and a partnership with Concord Healthcare in Hong Kong and Macau.
Across Asia Pacific, rising medical inflation has emerged as a significant concern. In Singapore alone, Mercer Marsh Benefits estimated in June that medical trends will increase by 11% in 2025. Experts cite several factors behind the surge: advances in medical technology, an ageing population, rising cases of chronic conditions and cancer, insufficient pricing transparency, and overconsumption.





